Expert Review of Pharmacoeconomics and Outcomes Research,volume 13,issue 2  (04-2013)

Period of time： 2013年2期

Publisher： Informa Healthcare

Founded in： 2001

Total resources： 4

ISSN： 1473-7167

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Expert Review of Pharmacoeconomics and Outcomes Research,volume 13,issue 2

Menu

Irrelevance of explicit cost-effectiveness thresholds when coverage decisions can be reversed

By Basu Anirban in (2013)

Expert Review of Pharmacoeconomics and Outcomes Research,volume 13,issue 2 , Vol. 13, Iss. 2, 2013-04 , pp. 163-165

Informa Healthcare

Abstract Access to resources Recommend Favorite

News in brief

By in (2013)

Expert Review of Pharmacoeconomics and Outcomes Research,volume 13,issue 2 , Vol. 13, Iss. 2, 2013-04 , pp. 167-169

Informa Healthcare

Abstract Access to resources Recommend Favorite

Cost-effectiveness of natalizumab in multiple sclerosis: an updated systematic review

By Koeser Leonardo,McCrone Paul in (2013)

Expert Review of Pharmacoeconomics and Outcomes Research,volume 13,issue 2 , Vol. 13, Iss. 2, 2013-04 , pp. 171-182

Informa Healthcare

Abstract Access to resources Recommend Favorite

Introduction to patient-reported outcome item banks: issues in minority aging research

By Templin Thomas N,Hays Ron D,Gershon Richard C,Rothrock Nan,Jones Richard N,Teresi Jeanne A,Stewart Anita,Weech-Maldonado Robert,Wallace Steve in (2013)

Expert Review of Pharmacoeconomics and Outcomes Research,volume 13,issue 2 , Vol. 13, Iss. 2, 2013-04 , pp. 183-186

Informa Healthcare

Abstract Access to resources Recommend Favorite

Hospitalizations for chronic obstructive pulmonary disease exacerbations and their impact on disease and subsequent morbidity and mortality

By Antoniu Sabina Antonela,Carone Mauro in (2013)

Expert Review of Pharmacoeconomics and Outcomes Research,volume 13,issue 2 , Vol. 13, Iss. 2, 2013-04 , pp. 187-189

Informa Healthcare

Abstract Access to resources Recommend Favorite

Application of electronic medical record data for health outcomes research: a review of recent literature

By Lin Junji,Jiao Tianze,Biskupiak Joseph E,McAdam-Marx Carrie in (2013)

Expert Review of Pharmacoeconomics and Outcomes Research,volume 13,issue 2 , Vol. 13, Iss. 2, 2013-04 , pp. 191-200

Informa Healthcare

Abstract Access to resources Recommend Favorite

Disparity implications of the Medicare medication therapy management eligibility criteria: a literature review

By Munshi Kiraat D,Shih Ya-Chen T,Brown Lawrence M,Dagogo-Jack Samuel,Wan Jim Y,Wang Junling in (2013)

Expert Review of Pharmacoeconomics and Outcomes Research,volume 13,issue 2 , Vol. 13, Iss. 2, 2013-04 , pp. 201-216

Informa Healthcare

Abstract Access to resources Recommend Favorite

Assessment of health-related quality of life in pediatric hematopoietic stem cell transplant recipients: progress, challenges and future directions

By Parsons Susan K,Tighiouart Hocine,Terrin Norma in (2013)

Expert Review of Pharmacoeconomics and Outcomes Research,volume 13,issue 2 , Vol. 13, Iss. 2, 2013-04 , pp. 217-225

Informa Healthcare

Abstract Access to resources Recommend Favorite

Pharmacoeconomics of empirical antifungal use in febrile neutropenic hematological malignancy and hematopoietic stem cell transplant patients

By Turner Stuart J,Chen Sharon CA,Slavin Monica A,Kong David CM in (2013)

Expert Review of Pharmacoeconomics and Outcomes Research,volume 13,issue 2 , Vol. 13, Iss. 2, 2013-04 , pp. 227-235

Informa Healthcare

Abstract Access to resources Recommend Favorite

Cost-effectiveness of preventive interventions for depressive disorders: an overview

By Mihalopoulos Cathrine,Vos Theo in (2013)

Expert Review of Pharmacoeconomics and Outcomes Research,volume 13,issue 2 , Vol. 13, Iss. 2, 2013-04 , pp. 237-242

Informa Healthcare

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 14 item(s)